Alzheimer's News -- ScienceDaily
2 days ago · Learn about Alzheimer's Disease symptoms such as memory loss and senile dementia. Find out about the treatments and causes, as well as the stages of Alzheimer's Disease and dementia.
Alzheimer’s disease may damage the brain in two phases
6 days ago · It also showed that star-shaped brain cells called astrocytes may provide resilience to or resist the harm caused by the disease. Researchers analyzed brains that are part of the Seattle Alzheimer’s Disease Brain Cell Atlas (SEA-AD), which is designed to create a highly detailed map of the brain damage that occurs during the disease. The ...
With new therapies that promise to slow Alzheimer’s disease ... - CNN
Jul 16, 2023 · Under new draft guidelines for the diagnosis of Alzheimer’s disease, unveiled on Sunday at a large international gathering of physicians and researchers, these memory tests would take a...
New Treatment Reverses Alzheimer’s Disease Signs
Dec 20, 2023 · PHILADELPHIA – A “chaperone” molecule that slows the formation of certain proteins reversed disease signs, including memory impairment, in a mouse model of Alzheimer’s disease, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer …
May 6, 2024 · Scientists are proposing a new way of understanding the genetics of Alzheimer’s that would mean that up to a fifth of patients would be considered to have a genetically caused form of the...
In breakthrough Alzheimer’s discovery, Emory research team …
Aug 12, 2024 · New findings out of Emory University are challenging existing theories about the origins of Alzheimer’s, the leading cause of dementia in the elderly worldwide. A team led by researchers at the Goizueta Brain Health Institute has found strong evidence supporting a new understanding of the mechanism behind Alzheimer’s disease.
FDA approves a second Alzheimer's drug, Eli Lilly's Kisunla - AP News
Jul 2, 2024 · WASHINGTON (AP) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment.
New Drug Approved for Early Alzheimer’s - The New York Times
Jul 2, 2024 · The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted with hope, disappointment and...
First Alzheimer’s drug to slow disease progression gets full FDA ...
Jul 7, 2023 · The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease.
Lilly's Alzheimer’s drug that can slow disease gets ... - NBC News
Jun 10, 2024 · A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with mild dementia...